REVB Q1 2023 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

REVBRevelation Biosciences, Inc.

$2M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$6,263

Operating Income

-$2M

Net Income

$6M

EPS (Diluted)

$942.76

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$32,095

Balance Sheet

Total Assets

$18M

Total Liabilities

$8M

Stockholders' Equity

$10M

Cash & Equivalents

$18M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$6,263	-$21,222	+70.5%
Operating Income	-$2M	-$7M	+75.4%
Net Income	$6M	-$7M	+193.1%